• PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Tech alert: Advertising therapeutic goods with COVID-19 testing advice

05 Oct 2021 3:16 PM | Anonymous member (Administrator)

In recognition of the desire by sponsors and advertisers of therapeutic goods to contribute to the dissemination of the Government's public health messaging about COVID-19 testing, the TGA has issued a permission under section 42DK of the Act, which allows advertisers of certain therapeutic goods included on the ARTG (including listed medicines) to use specific statements that expressly refer to COVID-19 in the context of advising individuals to follow health advice about COVID-19 testing.

The TGA has provided specific wording for the permitted Covid-19 testing statements and has also provided other general cautions about remaining in advertising compliance.

The use of the statements is voluntary and the permission ceases on 31 December 2022.

General statements without reference to COVID-19 may also be used and examples are provided in the new guidance.

Please read today’s technical alert for more information,

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software